We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,205

Google, Tesla, patent pooling and trolls a brief history of patents
  • Shelston IP
  • Australia
  • September 30 2015

It is hard to believe there was a time when tension did not exist between, on the one hand, the granting of patent rights and, on the other, free

Objections to business method patents: mere presentations of information
  • Fisher Adams Kelly
  • Australia
  • September 29 2015

In November last year the Australian Full Federal Court handed down its decision in Research Affiliates LLC v Commissioner of Patents concerning the

Patent licensing update
  • AJ Park
  • Australia, New Zealand, USA
  • September 24 2015

This decision is important for exclusive licensees who have (or think they have) the right to sue for infringement of a licensed patent in Australia

Stating the obvious: textual approach to obviousness
  • FAL Lawyers
  • Australia
  • September 23 2015

On September 2 2015 the High Court handed down a widely anticipated decision in AstraZeneca AB v Aptoex Pty Ltd.(1) The court unanimously dismissed

Australian High Court rules rosuvastatin low dose patent obvious
  • K&L Gates
  • Australia
  • September 16 2015

In an eagerly awaited decision the Australian High Court has upheld a decision of a five judge bench of the Full Federal Court that AstraZeneca’s

Need more time? Don’t stress! Australia and New Zealand national phase deadline for pre-America Invents Act PCT applications
  • Spruson & Ferguson
  • Australia
  • September 11 2015

We appreciate our American colleagues are currently battling a wave of foreign PCT national phase entry patent filings, following the rush of US

High Court upholds finding that Crestor patent is invalid
  • Corrs Chambers Westgarth
  • Australia
  • September 10 2015

In the much anticipated AstraZeneca AB v Apotex Pty Ltd, the High Court of Australia unanimously upheld a decision by an enlarged Full Federal Court

Will Australia follow the US and prohibit the patenting of genes and biological material?
  • Shelston IP
  • Australia
  • September 9 2015

A decision is expected later this year from the Australian High Court in D’Arcy v Myriad Genetics Inc. This case is essentially equivalent to the US

High Court confirms proper approach to assessing inventive step
  • Minter Ellison
  • Australia
  • September 9 2015

The High Court in Australia last week handed down its decision in the patent dispute regarding blockbuster cholesterol drug rosuvastatin (sold by

Australian High Court confirms common sense approach to whether an invention is obvious
  • Fisher Adams Kelly
  • Australia
  • September 9 2015

One of the grounds most often claimed by parties seeking to oppose or invalidate a patent is that of 'obviousness' or 'lack of inventive step' - in